Chlamydia trachomatis and Mycoplasma genitalium Plasma Antibodies in Relation to Epithelial Ovarian Tumors

Table 4

Clinical characteristics of women with type II tumors and plasma samples drawn 1.3–5.1 years prior to diagnosis.

Clinical characteristics	Type II tumors with prospective plasma samples (𝑛=7)
Age, y	62 (56–69)
Menarche, y	14 (12–16)
Menopause, y	50 (41–60)
Parity	3 (0–5)
0 children	2 (29%)
≥3 children	4 (57%)
Oral contraceptive pill use ≥1 year^a	2 (33%), 𝑛=6
Past or current HRT use	2 (29%)
Past or current smoking	2 (29%)
History of PID	2 (29%)
BMI	26 (20–31)
Histology
Serous ovarian cancer	4
Mixed epithelial ovarian cancer	1
Undifferentiated ovarian cancer	1
SSPC	1

Values are presented as medians and range (minimum and maximum values of age, menarche, menopause, parity, and BMI); or number and percentage of patients in each group (0 children, ≥3 children, oral contraceptive pill use ≥1 year, past or current HRT use, past or current smoking, history of PID).
HRT: hormone replacement therapy; PID: pelvic inflammatory disease; BMI: body mass index; SSPC: Serous Surface Papillary Carcinoma.
^aMissing data in one case.